tradingkey.logo
tradingkey.logo
Search

Amgen Inc - FDA Broadens Repatha Use For Cardiovascular Risk

ReutersAug 25, 2025 1:01 PM
facebooktwitterlinkedin

- Amgen Inc AMGN.O:

  • AMGEN INC - FDA BROADENS REPATHA USE FOR CARDIOVASCULAR RISK

  • AMGEN INC - UPDATE REMOVES PRIOR CV DISEASE DIAGNOSIS REQUIREMENT

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI